These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37121168)

  • 1. Wolbachia Ferrochelatase as a potential drug target against filarial infections.
    Biney C; Graham GE; Asiedu E; Sakyi SA; Kwarteng A
    J Mol Graph Model; 2023 Jul; 122():108490. PubMed ID: 37121168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target.
    Wu B; Novelli J; Foster J; Vaisvila R; Conway L; Ingram J; Ganatra M; Rao AU; Hamza I; Slatko B
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e475. PubMed ID: 19597542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational screening of potential inhibitors targeting MurF of Brugia malayi Wolbachia through multi-scale molecular docking, molecular dynamics and MM-GBSA analysis.
    Poopandi S; Sundaraj R; Rajmichael R; Thangaraj S; Dhamodharan P; Biswal J; Malaisamy V; Jeyaraj Pandian C; Jeyaraman J
    Mol Biochem Parasitol; 2021 Nov; 246():111427. PubMed ID: 34666103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate produced by Brugia spp. via glycolysis is essential for maintaining the mutualistic association between the parasite and its endosymbiont, Wolbachia.
    Voronin D; Schnall E; Grote A; Jawahar S; Ali W; Unnasch TR; Ghedin E; Lustigman S
    PLoS Pathog; 2019 Sep; 15(9):e1008085. PubMed ID: 31568486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humans from Wuchereria bancrofti endemic area elicit substantial immune response to proteins of the filarial parasite Brugia malayi and its endosymbiont Wolbachia.
    Jha R; Gangwar M; Chahar D; Setty Balakrishnan A; Negi MP; Misra-Bhattacharya S
    Parasit Vectors; 2017 Jan; 10(1):40. PubMed ID: 28118850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filamentation temperature-sensitive protein Z (FtsZ) of Wolbachia, endosymbiont of Wuchereria bancrofti: a potential target for anti-filarial chemotherapy.
    Sharma R; Hoti SL; Vasuki V; Sankari T; Meena RL; Das PK
    Acta Trop; 2013 Mar; 125(3):330-8. PubMed ID: 23262214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endosymbiotic Wolbachia of parasitic filarial nematodes as drug targets.
    Rao RU
    Indian J Med Res; 2005 Sep; 122(3):199-204. PubMed ID: 16251775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
    Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
    J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections.
    Bakowski MA; Shiroodi RK; Liu R; Olejniczak J; Yang B; Gagaring K; Guo H; White PM; Chappell L; Debec A; Landmann F; Dubben B; Lenz F; Struever D; Ehrens A; Frohberger SJ; Sjoberg H; Pionnier N; Murphy E; Archer J; Steven A; Chunda VC; Fombad FF; Chounna PW; Njouendou AJ; Metuge HM; Ndzeshang BL; Gandjui NV; Akumtoh DN; Kwenti TDB; Woods AK; Joseph SB; Hull MV; Xiong W; Kuhen KL; Taylor MJ; Wanji S; Turner JD; Hübner MP; Hoerauf A; Chatterjee AK; Roland J; Tremblay MS; Schultz PG; Sullivan W; Chu XJ; Petrassi HM; McNamara CW
    Sci Transl Med; 2019 May; 11(491):. PubMed ID: 31068442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of Recombinase A from Wolbachia endosymbiont of filarial nematode Brugia malayi (wBmRecA).
    Gangwar M; Jha R; Goyal M; Srivastava M
    Int J Parasitol; 2021 Sep; 51(10):841-853. PubMed ID: 34273392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the metabolic interplay between a parasitic worm and its bacterial endosymbiont allows the identification of novel drug targets.
    Curran DM; Grote A; Nursimulu N; Geber A; Voronin D; Jones DR; Ghedin E; Parkinson J
    Elife; 2020 Aug; 9():. PubMed ID: 32779567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose and Glycogen Metabolism in Brugia malayi Is Associated with Wolbachia Symbiont Fitness.
    Voronin D; Bachu S; Shlossman M; Unnasch TR; Ghedin E; Lustigman S
    PLoS One; 2016; 11(4):e0153812. PubMed ID: 27078260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wolbachia bacteria of filarial nematodes: a target for control?
    Taylor MJ; Bandi C; Hoerauf AM; Lazdins J
    Parasitol Today; 2000 May; 16(5):179-80. PubMed ID: 10782070
    [No Abstract]   [Full Text] [Related]  

  • 15. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections.
    Schiefer A; Hübner MP; Krome A; Lämmer C; Ehrens A; Aden T; Koschel M; Neufeld H; Chaverra-Muñoz L; Jansen R; Kehraus S; König GM; Pogorevc D; Müller R; Stadler M; Hüttel S; Hesterkamp T; Wagner K; Pfarr K; Hoerauf A
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008930. PubMed ID: 33284808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifilarial activity of caffeic acid phenethyl ester on Brugia pahangi in vitro and in vivo.
    Al-Abd NM; Nor ZM; Junaid QO; Mansor M; Hasan MS; Kassim M
    Pathog Glob Health; 2017 Oct; 111(7):388-394. PubMed ID: 29065795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Eagle effect in the Wolbachia-worm symbiosis.
    Bulman CA; Chappell L; Gunderson E; Vogel I; Beerntsen B; Slatko BE; Sullivan W; Sakanari JA
    Parasit Vectors; 2021 Feb; 14(1):118. PubMed ID: 33627171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bma-LAD-2, an Intestinal Cell Adhesion Protein, as a Potential Therapeutic Target for Lymphatic Filariasis.
    Flynn AF; Taylor RT; Pazgier ME; Bennuru S; Lindrose AR; Sterling SL; Morris CP; Gleeson BI; Maugel TK; Nutman TB; Mitre E
    mBio; 2022 Jun; 13(3):e0374221. PubMed ID: 35475643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi.
    Bilsland E; Bean DM; Devaney E; Oliver SG
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004401. PubMed ID: 26812604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayi.
    Shahab M; Verma M; Pathak M; Mitra K; Misra-Bhattacharya S
    PLoS One; 2014; 9(6):e99884. PubMed ID: 24941309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.